相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。p53 and its mutants in tumor cell migration and invasion
Patricia A. J. Muller et al.
JOURNAL OF CELL BIOLOGY (2011)
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
Can Liu et al.
NATURE MEDICINE (2011)
Frequent Downregulation of miR-34 Family in Human Ovarian Cancers
David C. Corney et al.
CLINICAL CANCER RESEARCH (2010)
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
Ashour Ahmed Ahmed et al.
JOURNAL OF PATHOLOGY (2010)
Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion
Katharine D. Grugan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Blinded by the Light: The Growing Complexity of p53
Karen H. Vousden et al.
CELL (2009)
Mutant p53 Drives Invasion by Promoting Integrin Recycling
Patricia A. J. Muller et al.
CELL (2009)
A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis
Maddalena Adorno et al.
CELL (2009)
p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug
Shu-Ping Wang et al.
NATURE CELL BIOLOGY (2009)
Awakening guardian angels: drugging the p53 pathway
Christopher J. Brown et al.
NATURE REVIEWS CANCER (2009)
The biology of ovarian cancer: new opportunities for translation
Robert C. Bast et al.
NATURE REVIEWS CANCER (2009)
Sp1: Emerging roles - Beyond constitutive activation of TATA-less housekeeping genes
Inken Wierstra
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
MicroRNAs Impair MET-Mediated Invasive Growth
Cristina Migliore et al.
CANCER RESEARCH (2008)
Growth-inhibitory and tumor-suppressive functions of p53 depend on its repression of CD44 expression
Samuel Godar et al.
CELL (2008)
The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss
Tamara Terzian et al.
GENES & DEVELOPMENT (2008)
Drug development of MET inhibitors: targeting oncogene addiction and expedience
Paolo M. Comoglio et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Mutant p53 attenuates the SMAD-dependent transforming growth factor β1 (TGF-β1) signaling pathway by repressing the expression of TGF-β receptor type II
Eyal Kalo et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth
David C. Corney et al.
CANCER RESEARCH (2007)
Loss of p53 promotes RhoA-ROCK-dependent cell migration and invasion in 3D matrices
Gilles Gadea et al.
JOURNAL OF CELL BIOLOGY (2007)
A microRNA component of the p53 tumour suppressor network
Lin He et al.
NATURE (2007)
c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion
Kenjiro Sawada et al.
CANCER RESEARCH (2007)
The androgen receptor negatively regulates the expression of c-Met: Implications for a novel mechanism of prostate cancer progression
Meletios Verras et al.
CANCER RESEARCH (2007)
Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship
David W. Kindelberger et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells
Pierre-Olivier Esteve et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The Met pathway: master switch and drug target in cancer progression
Massimiliano Mazzone et al.
FASEB JOURNAL (2006)
Gene expression programs in response to hypoxia: Cell type specificity and prognostic significance in human cancers
JT Chi et al.
PLOS MEDICINE (2006)
Mutation and expression of the TP53 gene in early stage epithelial ovarian carcinoma
MM Leitao et al.
GYNECOLOGIC ONCOLOGY (2004)
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
KP Olive et al.
CELL (2004)
Spectrum of p53 tumor suppressor gene mutations and breast cancer survival
H Lai et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
Why did p53 gene therapy fail in ovarian cancer?
AG Zeimet et al.
LANCET ONCOLOGY (2003)
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene
S Pennacchietti et al.
CANCER CELL (2003)
Sp1 and Sp3 transcription factors synergistically regulate HGF receptor gene expression in kidney
XH Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2003)
CD44 is required for two consecutive steps in HGF/c-Met signaling
V Orian-Rousseau et al.
GENES & DEVELOPMENT (2002)
Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer
JMJ Piek et al.
JOURNAL OF PATHOLOGY (2001)
Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21WAF1/Cip1 gene by the p53 tumor suppressor protein
G Koutsodontis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Changes in p53 expression in mouse fibroblasts can modify motility and extracellular matrix organization
A Alexandrova et al.
ONCOGENE (2000)
分享论文
